EditorialsResponding to America’s Iatrogenic Epidemic of Prescription Opioid Addiction and OverdoseVon Korff, Michael R. ScD*; Franklin, Gary MD, MPH†,‡ Author Information *Group Health Research Institute †Departments of Environmental and Occupational Health Sciences, Neurology, and Health Services, University of Washington, Seattle ‡Washington State Department of Labor and Industries, Olympia, WA M.R.V.K. and G.F. serve as uncompensated board members of Physicians for Responsible Opioid Prescribing, a nonprofit organization that advocates for more cautious and selective opioid prescribing. M.R.V.K. is the principal investigator or coinvestigator on grants to the Group Health Research Institute from Pfizer Inc. and from the Campbell Alliance (a consortium of drug companies conducting FDA-mandated postmarketing surveillance studies of opioids) to carry out research on the long-term use of opioid analgesics, associated risks, and patient outcomes. Reprints: Michael R.Von Korff, ScD, Group Health Research Institute, 1730 Minor Avenue, Suite 1600, Seattle, WA 98101. E-mail: [email protected]. Medical Care 54(5):p 426-429, May 2016. | DOI: 10.1097/MLR.0000000000000537 Buy Metrics Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.